Tectonic Therapeutic, Inc.
5.60%
1,028,674
1681087
Feb 4, 2025
Feb 7, 2025, 05:51 PM
Reporting Persons (3)
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| VV Manager II, LLC | Other | 5.60% | 1,028,674 | 0 | 1,028,674 |
| Vida Ventures II, LLC | Other | 5.40% | 1,000,900 | 0 | 1,000,900 |
| Vida Ventures II-A, LLC | Other | 0.20% | 27,774 | 0 | 27,774 |
Disclosure Items (6)
Common Stock, $0.0001 par value per share
Tectonic Therapeutic, Inc.
490 ARSENAL WAY, WATERTOWN, MA, 02472
This Schedule 13D is filed by Vida Ventures II, LLC (Vida II), Vida Ventures II-A, LLC (Vida II-A) and VV Manager II, LLC (VV Manager II and, with Vida II and Vida II-A, collectively, the Reporting Persons). The agreement among the Reporting Persons to file jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act is attached as Exhibit A to the Original Schedule 13D.
The principal business office of the Reporting Persons is 40 Broad Street, Suite 201, Boston, MA 02109.
The principal business of the Reporting Persons is venture capital investments. VV Manager II is the manager of each of Vida II and Vida II-A.
During the last five years, none of the Reporting Persons was a party to a civil proceeding of a judicial of administrative body of competent jurisdiction or were subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
Each of the Reporting Persons is a limited liability company organized in the state of Delaware.
The information set forth in Item 3 of the Original Schedule 13D is incorporated herein by reference.
See Items 7-11 of the cover pages of this Amendment No. 1. The information reported on such cover pages is reported as of February 5, 2025.
See Items 7-11 of the cover pages of this Amendment No. 1. The information reported on such cover pages is reported as of February 5, 2025.
Except as reported in this Statement, none of the Reporting Entities has affected any transactions in the Issuer's securities within the past 60 days.
Under certain circumstances set forth in the limited liability company agreements of each of Vida II and Vida II-A, VV Manager II and the members of each of Vida II and Vida II-A may be deemed to have the right to receive dividends from, or the proceeds from, the sale of shares of the Issuer owned by such entity of which they are a partner.
Not applicable.
The information set forth in Item 3 of the Original Schedule 13D is incorporated herein by reference.